 |
|
|
 |
|
New Hormone Treatment Fights Certain Breast Cancers
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 "The results of our analysis show that LHRH agonists provide an effective additional class of agents for the treatment of premenopausal women with hormone-sensitive breast cancer," the team concluded.
Treating breast cancer is increasingly done by combining treatments, Thun said. Doctors may want to now consider adding LHRH to chemotherapy or tamoxifen, he said.
"This is definitely an approach that might be used," Thun said. "The challenge is to determine what the benefit of LHRH is, particularly in the presence of chemotherapy and tamoxifen."
Text Continues Below

More information
For more information on breast cancer, visit the U.S. National Cancer Institute.
Page: << Prev | 1 | 2
|
Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 5/18/2007
|
 |

SOURCES: Michael Thun, M.D., head, epidemiological research, American Cancer Society, Atlanta; May 19, 2007, The Lancet
|